Kansikuva

A Promising Single Oral Disintegrating Tablet for Co-Delivery of Pitavastatin Calcium and Lornoxicam Using Co-Processed Excipients: Formulation, Characterization and Pharmacokinetic Study

Mahmoud H Teaima,1 Khaled M Abdel-Haleem,2 Rewan Osama,2 Mohamed A El-Nabarawi,1 Osama S Elnahas2 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, October 6 University...

Tallennettuna:

Bibliografiset tiedot
Päätekijät:	Teaima MH (Tekijä), Abdel-Haleem KM (Tekijä), Osama R (Tekijä), El-Nabarawi MA (Tekijä), Elnahas OS (Tekijä)
Aineistotyyppi:	Kirja
Julkaistu:	Dove Medical Press, 2021-10-01T00:00:00Z.
Aiheet:	article
Linkit:	Connect to this object online.
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia

Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method
Tekijä: Abdelmonem R, et al.
Julkaistu: (2021)

A Novel Lactose/MCC/L-HPC Triple-Based Co-Processed Excipients with Improved Tableting Performance Designed for Metoclopramide Orally Disintegrating Tablets
Tekijä: Xiaorong Dai, et al.
Julkaistu: (2024)

Pharmacokinetic Properties of Single- and Multiple-Dose Pitavastatin Calcium Tablets in Healthy Chinese Volunteers
Tekijä: Zhu Luo, MD, et al.
Julkaistu: (2015)

Design and Optimization of Pioglitazone Hydrochloride Self-Nanoemulsifying Drug Delivery System (SNEDDS) Incorporated into an Orally Disintegrating Tablet
Tekijä: Mahmoud Teaima, et al.
Julkaistu: (2022)

Design and evaluation of lornoxicam bilayered tablets for biphasic release
Tekijä: Songa Ambedkar Sunil, et al.
Julkaistu: (2012)

Study of Orally Disintegrating Tablets Using Erythritol as an Excipient Produced by Moisture-Activated Dry Granulation (MADG)
Tekijä: Mizuki Yamada, et al.
Julkaistu: (2022)

Promising Swellable Floating Bupropion Tablets: Formulation, in vitro/in vivo Evaluation and Comparative Pharmacokinetic Study in Human Volunteers
Tekijä: Teaima M, et al.
Julkaistu: (2020)

Functionality evaluation of co-processed excipients as diluents in tablets manufactured by wet granulation
Tekijä: Eshovo Apeji Y., et al.
Julkaistu: (2021)

Optimization of Theophylline Tablet Formula Using CoProcessed Excipients of Lactose and Avicel
Tekijä: Hayatus Sa`adah, et al.
Julkaistu: (2011)

Lornoxicam gastro retentive floating matrix tablets: Design and in vitro evaluation
Tekijä: S Sathiyaraj, et al.
Julkaistu: (2011)

Swelling of Zein Matrix Tablets Benchmarked against HPMC and Ethylcellulose: Challenging the Matrix Performance by the Addition of Co-Excipients
Tekijä: Alberto Berardi, et al.
Julkaistu: (2019)

Effects of Omega-3 Co-Administered with Therapeutic Dose of lornoxicam on Male Rats' Liver
Tekijä: Israa A. Majeed, et al.
Julkaistu: (2019)

FORMULATION OF CHLORPHENIRAMINE MALEATE TABLETS USING CO-PROCESSED EXCIPIENT AS A FILLER AND BINDER
Tekijä: Yandi Syukri, et al.
Julkaistu: (2019)

compressional force in disintegration of tablets containing disintegrants of different mechanisms
Tekijä: Chakri Thongplengsri
Julkaistu: (2013)

Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients
Tekijä: Isabel González-Álvarez, et al.
Julkaistu: (2022)

Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats
Tekijä: Shahinaze A. Fouad, et al.
Julkaistu: (2023)

Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus
Tekijä: Kawai Y, et al.
Julkaistu: (2011)

Design and Optimization of Lornoxicam Dispersible Tablets Using Quality by Design (QbD) Approach
Tekijä: Nawaf Almotairi, et al.
Julkaistu: (2022)

Particle Engineering of Chitosan and Kaolin Composite as a Novel Tablet Excipient by Nanoparticles Formation and Co-Processing
Tekijä: Chonwipa Yarangsee, et al.
Julkaistu: (2021)

Application of Machine-Learning Algorithms for Better Understanding of Tableting Properties of Lactose Co-Processed with Lipid Excipients
Tekijä: Jelena Djuris, et al.
Julkaistu: (2021)

Proniosomal Telmisartan Tablets: Formulation, in vitro Evaluation and in vivo Comparative Pharmacokinetic Study in Rabbits
Tekijä: Teaima MH, et al.
Julkaistu: (2020)

Formulation of Chewable Tablets Containing Carbamazepine-β-cyclodextrin Inclusion Complex and F-Melt Disintegration Excipient. The Mathematical Modeling of the Release Kinetics of Carbamazepine
Tekijä: Adina Magdalena Musuc, et al.
Julkaistu: (2021)

Optimized Taste-Masked Microparticles for Orally Disintegrating Tablets as a Promising Dosage Form for Alzheimer's Disease Patients
Tekijä: Lalinthip Sutthapitaksakul, et al.
Julkaistu: (2021)

Evaluating the bioequivalence of two pitavastatin calcium formulations based on IVIVC modeling and clinical study
Tekijä: Jiaying Wang, et al.
Julkaistu: (2023)

Development and Evaluation of Ondansetron Orally Disintegrating Tablets
Tekijä: Bipin Pustake, et al.
Julkaistu: (2019)

Development and evaluation of ofloxacin orally disintegrating tablets
Tekijä: Badrinath Pralhadrao Mohite, et al.
Julkaistu: (2012)

Formulation and evaluation of orally disintegrating clopidogrel tablets
Tekijä: Gamal Mohamed Mahrous, et al.

Formulation and evaluation of fast disintegrating tablet of glimepiride
Tekijä: Arooj Khalid, et al.
Julkaistu: (2018)

Azeotropic mixture used for development and validation of Lornoxicam in bulk and its tablet dosage form by spectrophotometric method
Tekijä: Prajesh Prajapati, et al.
Julkaistu: (2012)

Natural Polymer Chitosan as Super Disintegrant in Fast Orally Disintegrating Meloxicam Tablets: Formulation and Evaluation
Tekijä: Gailute Draksiene, et al.
Julkaistu: (2021)

Rapid disintegrating tablets of simvastatin dispersions in polyoxyethylene–polypropylene block copolymer for maximized disintegration and dissolution
Tekijä: Balata GF, et al.
Julkaistu: (2016)

Application of Design of Experiment for development of orally disintegrating tablets
Tekijä: Irina Ermolina, et al.
Julkaistu: (2023)

Formulation and development of paediatric orally disintegrating carbamazepine tablets
Tekijä: R Canadell-Heredia, et al.
Julkaistu: (2022)

Optimized furosemide taste masked orally disintegrating tablets
Tekijä: Mohamed Abbas Ibrahim, et al.
Julkaistu: (2017)

Fast disintegrating tablets: Opportunity in drug delivery system
Tekijä: Ved Parkash, et al.
Julkaistu: (2011)

The Use of Capsule Endoscopy to Determine Tablet Disintegration In Vivo
Tekijä: Lasse I. Blaabjerg, et al.
Julkaistu: (2020)

Formulation and in vitro Evaluations of Paracetamol Orally Disintegrating Tablets
Tekijä: Azmiera Azimuddin, et al.
Julkaistu: (2023)

Applications of β-limit Dextrin as a Matrix Forming Excipient for Fast Disintegrating Buccal Dosage Formats
Tekijä: Xin Qi, et al.
Julkaistu: (2013)

Safety of lornoxicam in G-6-PDH deficiency
Tekijä: G. Perpignano, et al.
Julkaistu: (2003)

Lornoxicam-Loaded Cubosomes: - Preparation and In vitro Characterization.
Tekijä: Rasha Saadi Younus Alkawak, et al.
Julkaistu: (2022)